Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Effect of rituximab on the peripheral blood and cerebrospinal fluid B cells in patients with primary progressive multiple sclerosis.
Overcoming barriers in progressive multiple sclerosis research.
The potential role of epigenetic modifications in the heritability of multiple sclerosis.
Simvastatin as add-on therapy to interferon β-1a for relapsing-remitting multiple sclerosis (SIMCOMBIN study): a placebo-controlled randomised phase 4 trial.
In vivo gene expression revealed by cDNA arrays: the pattern in relapsing-remitting multiple sclerosis patients compared with normal subjects.
Normal-appearing white matter in multiple sclerosis is in a subtle balance between inflammation and neuroprotection.
Epigenetic changes in patients with multiple sclerosis.
Dalfampridine sustained-release for symptomatic improvement of walking speed in patients with multiple sclerosis.
Design, engineering, and production of human recombinant t cell receptor ligands derived from human leukocyte antigen DR2.
Sanofi withdraws Campath in US and EU
A 2-year observational study of patients with relapsing-remitting multiple sclerosis converting to glatiramer acetate from other disease-modifying therapies: the COPTIMIZE trial.
Diminished Th17 (not Th1) responses underlie multiple sclerosis disease abrogation after hematopoietic stem cell transplantation.
Molecular properties of epithelial, amiloride-blockable Na+ channels.
Does interferon Beta-1a impact pure-tone hearing sensitivity among individuals with multiple sclerosis?
Effects of rituximab on lymphocytes in multiple sclerosis and neuromyelitis optica.
Phase II Cladribine Add-on to Interferon-beta (IFN-b) Therapy in MS Subjecs With Active Disease (ONWARD)
Saccadic intrusions: review and update.
Dalfampridine may activate latent trigeminal neuralgia in patients with multiple sclerosis.
Emerging roles of endothelial cells in multiple sclerosis pathophysiology and therapy.
The multiple sclerosis rating scale, revised (MSRS-R): Development, refinement, and psychometric validation using an online community.
A complex role of herpes viruses in the disease process of multiple sclerosis.
Rescue Therapy Using Rituximab for Multiple Sclerosis.
Safety and Efficacy of Fingolimod in Pediatric Patients With Multiple Sclerosis
Autologous attenuated T-cell vaccine (Tovaxin) dose escalation in multiple sclerosis relapsing-remitting and secondary progressive patients nonresponsive to approved immunomodulatory therapies.
Specific peripheral B cell tolerance defects in patients with multiple sclerosis.

Pages